SU1251904A1 - Composition for mineralization of teeth - Google Patents
Composition for mineralization of teeth Download PDFInfo
- Publication number
- SU1251904A1 SU1251904A1 SU843728873A SU3728873A SU1251904A1 SU 1251904 A1 SU1251904 A1 SU 1251904A1 SU 843728873 A SU843728873 A SU 843728873A SU 3728873 A SU3728873 A SU 3728873A SU 1251904 A1 SU1251904 A1 SU 1251904A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- sodium
- phosphate
- chloride
- teeth
- composition
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Il:io6pei44ine относитс к медицине, а именно к те);п1евтической стомато/югии, и может быть использовано дл профилактики и .1е К НИЯ кариеса.Il: io6pei44ine refers to medicine, namely to those of therapeutic dental / yugia, and can be used for prophylaxis and carpal carcinoma.
ll,i, и:и)Г)ретени вл етс новьинение адгезии к зубам.ll, i, and: i) D) retention is a new adhesion to the teeth.
(д)став дл минерализации зубон содержит основу и нротивокариозные соединени , в качестве основы используют ноли- улект)олитный комплекс полиутиленимина и полиакриловой кислоты в соотношении 1:1.5, а в качестве нротивокариозных соединений испо.1ьзук)г хлорисгый кальций, хлористый стронци. х.юристый ЦИНК, фосфорнокислый, двузаме1цениь:,|й натрий, фосфорнокислый однозамешенный калий, глицерофосфат натри , монофторфосфат натри , а в качестве си1ииак)1це1 о а1 ента ри и воду, компонентов.(e) becoming a mineral for the mineralization, the base contains nastocaryotic compounds, as a base they use a polyolefin – polyacrylic acid polyolines complex and a polyacrylic acid complex in a ratio of 1: 1.5, and chlorine calcium and strontium chloride as an anti-caries compounds. h.yurinic zinc, phosphate, dvuametseni:, th sodium, phosphate monohydrate potassium, sodium glycerophosphate, sodium monofluorophosphate, and as syltiac) 1ce1 o11 ri and water, components.
,1игносу,;1ьфонат tiaT- нри следуюн1ем соотношении, 1gnosu,; 1 tfonat tiaT- at the following ratio
1(),:1иакрилова 1 (),: 1 acrylic
кислотаacid
11о,чи тиленимин11o, chi tilenimine
Хл()1истый кальцийChl () pure calcium
Хло)исгый стронцийChlo) isgy strontium
Х.юрисгый цинкH.yurgy zinc
Ф()(-()ориокислый дву .(ам(. 1ненный натрийF () (- () oriocid bil. (Am (. 1nenny sodium
Ф осф о р н о к и ел ы и од н замещс иный калийPh osp o rn o k e el s and one n potassium is replaced
Г;1И1 ерофосфат натриG; 1I1 sodium erophosphate
:()ио(1торфосфат:() io (1phosphate
на I ри on i ri
,Пиг 11осуль({)()натPig 11osul ({) () nat
иа-|ри ia | ri
ВодаWater
Пример I- (томатоло1-ическое средство в виде 1е,1 гоюв т, добавл в растворы |1олиакри, 1()вой кис.юты (ПАК) и иолиути- ленимина (ПЭИ), вз тые в эквнмол рных соогношени х, соответствукмцие соли до 11о,Ц|()|() расг(.)рени . Приг отовленные раст- В( И.ЛК и ПЗП смешивают до получени , (КОЙ гелеобразной массы и нанос т на 11редва)ительно ()чин1енную поверхность зубов. Ж и.(неспособность (рабочее врем ) 2 3 мин.Example I- (tomato remedy in the form of 1E, 1 goyt, added to solutions | 1 acrylic, 1 () acidic acid (PAA) and iolyutilenimine (PEI), taken in equivalent molar terms, corresponding to salt up to 11o, C | () | () rasg (.) rhenium. Pickled plants (BLC and PPP are mixed to obtain (COY gel-like mass and put on 11 occasionally) it) () the dented surface of the teeth. . (inability (working time) 2 3 min.
При iioM компоненты берут в с, 1едук)- ших соогнон1ени х, мас.%:With iioM, the components are taken in with, 1) - their cone, wt.%:
Полиакрилова кси,:|ота 24,0 11(),1И:(1 иленимин15,4Polyacrylic XI,: | from 24.0 11 (), 1I: (1 ilenimine15.4
.Хлористый ка,1ьций1,68Chloride ka, 1, 1.68
Х.юристый cipoHiuni0,064H. Lawyer cipoHiuni0,064
Х.юрисгый цинк0,054H.yurisy zinc0,054
Фосфорнокислый дву- замешенный натрийО,,322Phosphate double-mixed sodium, 322
Ф()с(|)())н()кислый однозамешенный кали110,355 Г.тицерофосфат натри 0,,3 .онофторфосфат натри 1,95 Лигносуль(}1онат нагри 7,7 Вода ОстальноеF () with (|) ()) n () acidic mono-mixed potassium 110,355 G. sodium nitric phosphate 0, 3. Sodium ionofluorophosphate 1.95 Lignosul (} 1onate 7.7 water 7.7 Water Remaining
5five
00
5five
00
5five
00
5five
00
5five
Пример 2. Аналогичен нримеру 1, од- ко.мцоненты Г)е)ут в слс дуюши.х соот- )1()Н1ени , мас.%: П().1иакри;1ова Example 2. It is similar to example 1, but it is m.tsonenty G) e) ut in slushuyu.kh respectively-) 1 () H1eni, wt.%: P ().
кислота25,5acid25,5
Полиути.тенимин19,25Polyti.tenim19,25
Хлористый кальций3,08Calcium Chloride3.08
Хлористый С1ронцийf),l 18C1rontium chloride), l 18
Хлористый цинк0,(i5Zinc chloride, (i5
Фосфор нокисл ы и дву - замешенный натрий0,59Phosphoric acids and two - mixed sodium0.59
Фосфорнокислый однозамешенный калий0,()5 Глицерофосфат натрии0,55 ЛАонофторфосфат натри 2,55 Лигносу.,П)1|к)нат нагри 11,3 Вода Остальное Пример 3. Ана,югичен нримеру 1, однако компоненты берут в с, 1едук)1цих COOIHOIIIC- ни х, мас.%:Phosphate mono-mixed potassium0, () 5 Sodium glycerophosphate 0.55 L sodium sulfate phosphate 2.55 Lignos., P) 1 | (k) sodium heating 11.3 Water Remaining Example 3. Ana, Yugichen to number 1, however, components are taken in seconds, 5 units) 1 COOIHOIIIC- x, wt.%:
По,1иакрилова к и с;: от аBy, 1acrylic to and from ;: from
11о.чиути. 1енимин Х.тористый кальций Хлсфистый стронций .Хлористый цинк Фосфорнокислый дву- замен1енны1( натрий Фосфорнокислый одно- :1аме1цеиный калий Г,чицерофос(1)ат на ри .оно(|)тор((1ос({)ат нат|)и . 1игносул11ф()нат nai |)и 11 o.chuti. 1imine H. calcium sulfide Strontium hlphite. Zinc chloride Phosphate bilimide1 (sodium Phosphate mono-: 1me1-1 potassium G, chitserfos (1) atru .ono (|) torus ((1oc ({) nat nat)). () nat nai |) and
Пример 4. Аналогичен 11риме) 1, однако на 24,0 мае. ПАК берут 53.01 мае./,) ноли- диметила.миноутилметакрилаг (11Л..Л). Жи:(неснособность возрастаег до 4 5 мин. Пример 5. Аналогичен нримеру 2, однако па 19,25 мае./, П.ЛК i 59 мае./о ПЛЛ АЭЛ1А.Example 4. Similar to 11rime) 1, but at 24.0 May. PAK take 53.01 May /,) nolydimethyl.minouthylamine (11L..L). Ji: (incompatibility of age up to 4 5 minutes. Example 5. Similar to number 2, however, May 19.25. /, P.L.K. and 59 May. / O PLL AEL1A.
Пример 6. Аналогичен нримеру 3, однако на 27,0 мас.% ПАК берут 65 мас.% ПДМАЭМА.Example 6. Similar to example 3, however, at 27.0 wt.% PAA take 65 wt.% PDMAEMA.
П)именение среде гва к виде им обесне- чивае бо,чьн1ук) д,1ителы1ость действи нро- тивокариознь1х aieHTOB счет ад1 е:(ии гел к :iy6aM и дает во: можно1 ть умень- дцп ь чис,ло кли |ических ир(1Цедур.O) the naming of the medium to the form by which they become impaired, h1uk) d, 1l the body of action of the circulatory aieHTOB account ad1 e: (and gel to: iy6aM and allows you to: reduce the number of climatic ir (1Sedur.
.Многочисленные и: мерен и показа. и, что скорос ть выделени основных нротивока- )1юзных агентов и:( гелевог() средетва за 5 6 ч носто нна, что 11о:(вол ет нодде)- живать необходим1)1е терапевтически эффективные концентрации, н1Н чотвран1ак)Н1.ие де- минерали:(ацик) :(уб()в и сцособстнующио бо- ,iee 6bicT|)()it их реминера;|и: ации.. Multiple and: measurement and display. and, that the rate of release of the main anti-body agents and: (gel) () the medication is 5 6 hours long, which is 11 °: (it is necessary) to live is necessary 1) 1 therapeutically effective concentrations, H1H chotvran1ac H1 de - minerals: (acyc): (u () in and with the boosters, ie, 6bicT |) () it of their reminer; | and: ation.
111)имер исцо.)овани состава. Больной К. поступи, с диагнозом в111) imer istso.) Ovan composition. Patient K. do, with a diagnosis of
СГадИИ белО() . Бы, ,.и)ВаНОSgadii white (). Would, .i) WANO
1ред. 1ожен 1Ь 11 еостав, который наносили на зубы на 5 6 ч. После 3 а,икаций белое исчезло. Пред. юженный состав позвол ет ,:и)ват его д, лечен 1 и ро- фи, актики кариеса.1red March 1–11, which was applied to the teeth for 5–6 hours. After 3 hours, the white color disappeared. Prev the southern composition allows,: i) wat its d, is treated with 1 and rophy, aktiki caries.
27,0 23,127.0 23.1
4,54.5
0,320.32
0,1830.183
0,860.86
|).95|) .95
П.81P.81
3,15 15.0 ()ста,3.15 15.0 () hundred,
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU843728873A SU1251904A1 (en) | 1984-03-07 | 1984-03-07 | Composition for mineralization of teeth |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU843728873A SU1251904A1 (en) | 1984-03-07 | 1984-03-07 | Composition for mineralization of teeth |
Publications (1)
Publication Number | Publication Date |
---|---|
SU1251904A1 true SU1251904A1 (en) | 1986-08-23 |
Family
ID=21114478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU843728873A SU1251904A1 (en) | 1984-03-07 | 1984-03-07 | Composition for mineralization of teeth |
Country Status (1)
Country | Link |
---|---|
SU (1) | SU1251904A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2229919B (en) * | 1989-03-31 | 1993-04-14 | Sanyo Kokusaku Pulp Co | Composition for antiviral medicines |
US5888480A (en) * | 1995-01-17 | 1999-03-30 | Four Star Partners | Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth |
US5961958A (en) * | 1996-07-16 | 1999-10-05 | Four Star Partners | Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth |
EP2380565A1 (en) * | 2010-03-31 | 2011-10-26 | Lunamed AG | Compositions for dental treatment comprising Lipoteichoic acids or parts thereof like mono- or polyglycerphosphates |
-
1984
- 1984-03-07 SU SU843728873A patent/SU1251904A1/en active
Non-Patent Citations (1)
Title |
---|
За вка DE № 2313914, кл. А 61 К 7/18, 1980. * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2229919B (en) * | 1989-03-31 | 1993-04-14 | Sanyo Kokusaku Pulp Co | Composition for antiviral medicines |
US5888480A (en) * | 1995-01-17 | 1999-03-30 | Four Star Partners | Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth |
US5961958A (en) * | 1996-07-16 | 1999-10-05 | Four Star Partners | Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth |
EP2380565A1 (en) * | 2010-03-31 | 2011-10-26 | Lunamed AG | Compositions for dental treatment comprising Lipoteichoic acids or parts thereof like mono- or polyglycerphosphates |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4556561A (en) | Compositions and methods for topically fluoridating and/or mineralizing dental tissue | |
US5051401A (en) | Inhibition of mineral deposition by phosphorylated and related polyanionic peptides | |
GB1465308A (en) | Composition and method for treating scours and/or tetany | |
DE3366019D1 (en) | Phosphinylalkanoyl substituted imino acids | |
ATE1691T1 (en) | COMPOSITION TO COMBAT PLAQUE AND TARTAR FORMATION. | |
IL65137A (en) | (hetero)aroylimidazolones and pharmaceutical compositions containing them | |
FI58066C (en) | FLUORHALTIGT TANDVAORMEDEL | |
JPS6438017A (en) | Anticaries and antitartar composition containing zeolitic zinc cation | |
SU1251904A1 (en) | Composition for mineralization of teeth | |
GB1090340A (en) | Dentrifice composition | |
IL101561A0 (en) | Amino acid derivatives,their manufacture and pharmaceutical compositions containing them | |
AU2908189A (en) | Aqueous preparation based on mineral salts and acetic acid for the prevention and treatment of viral diseases | |
EP0391629A1 (en) | Inhibition of mineral deposition by phosphorylated and related polyanionic peptides | |
EP0020617B1 (en) | Dentifrice | |
HUT48464A (en) | Process for producing pharmaceutical composition for treating hypertonia and cardiac failure | |
SE7702078L (en) | ANTIBIOTICS | |
GB1522159A (en) | Process for the stabilisation of calciumhydrogenphosphate-dihydrate against hydrolysis | |
US2798816A (en) | Permanently sterilized dental material | |
US1162024A (en) | Means for softening water. | |
ATE134503T1 (en) | COMPOSITION WITH IMPROVED TASTE FOR STABILIZING DENTAL PROSTHESES | |
GB1401360A (en) | Pharmaceutical composition | |
BR9406629A (en) | Liquid antiacid compositions | |
SE8701887L (en) | NEW 4-PHENYL-4-OXO-2-BUTENIC ACID DERIVATIVES, THEIR PREPARATION PROCEDURES, THEIR USE AS MEDICINAL PRODUCTS AND COMPOSITIONS CONTAINING THEM | |
EP0030248B1 (en) | Dentifrice and method for controlling calculus | |
GB1522158A (en) | Process for the stabilisation of calcium hydrogenphosphate-dihydrate against hydrolysis |